Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson’s disease dementia brain

Oxidative stress and regulated cell death in Parkinson’s disease

(2021) P.A. Dionísio et al.   AGEING RESEARCH REVIEWS

Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson’s Disease Dementia

(2021) Melissa Scholefield et al.   Metabolites

Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer’s disease

(2020) Jingshu Xu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s Disease: review and meta‐analysis

(2020) Félix Javier Jiménez‐Jiménez et al.   EUROPEAN JOURNAL OF NEUROLOGY

Mitochondria and Parkinson’s Disease: Clinical, Molecular, and Translational Aspects

(2020) Max Borsche et al.   Journal of Parkinsons Disease

Changes in the metabolic profiles of the serum and putamen in Parkinson’s disease patients – In vitro and in vivo NMR spectroscopy studies

(2020) Beata Toczylowska et al.   BRAIN RESEARCH

Impairment of Motor Function Correlates with Neurometabolite and Brain Iron Alterations in Parkinson’s Disease

(2019) Beate Pesch et al.   Cells

Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington’s Disease

(2019) Stefano Patassini et al.   Metabolites

Enhancing glycolysis attenuates Parkinson’s disease progression in models and clinical databases

(2019) Rong Cai et al.   JOURNAL OF CLINICAL INVESTIGATION

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

(2018) Jin-Sung Park et al.   Current Neurology and Neuroscience Reports

Reduced occipital GABA in Parkinson disease with visual hallucinations

(2018) Michael J. Firbank et al.   NEUROLOGY

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease

(2018) Ruth L. O'Gorman Tuura et al.   Frontiers in Neurology

The Emerging Evidence of the Parkinson Pandemic

(2018) E. Ray Dorsey et al.   Journal of Parkinsons Disease

Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson’s disease using MEGA-PRESS MRS

(2017) Elsadig E. A. Elmaki et al.   JAPANESE JOURNAL OF RADIOLOGY

Epidemiology of Parkinson’s disease

(2017) Ole-Bjørn Tysnes et al.   JOURNAL OF NEURAL TRANSMISSION

Dementia in Parkinson's disease

(2017) Hasmet A. Hanagasi et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia

(2017) Jingshu Xu et al.   Metallomics

Diagnosis and management of dementia with Lewy bodies

(2017) Ian G. McKeith et al.   NEUROLOGY

Brain urea increase is an early Huntington’s disease pathogenic event observed in a prodromal transgenic sheep model and HD cases

(2017) Renee R. Handley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Examining alterations in GABA concentrations in the basal ganglia of patients with Parkinson’s disease using MEGA-PRESS MRS

(2017) Elsadig E. A. Elmaki et al.   Japanese Journal of Radiology

Oxidative stress and cellular pathologies in Parkinson’s disease

(2017) Lesly Puspita et al.   Molecular Brain

Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain

(2016) Stefano Patassini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia

(2016) Jingshu Xu et al.   Scientific Reports

Identification of elevated urea as a severe, ubiquitous metabolic defect in the brain of patients with Huntington's disease

(2015) Stefano Patassini et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The cerebellum in Parkinson’s disease

(2013) Tao Wu et al.   BRAIN

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease

(2013) Laura Dunn et al.   NEUROBIOLOGY OF AGING

Postmortem Brain Levels of Urate and Precursors in Parkinson's Disease and Related Disorders

(2013) Nikolaus R. McFarland et al.   Neurodegenerative Diseases

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

(2012) Bradley T. Hyman et al.   Alzheimers & Dementia

Elevated Pontine and Putamenal GABA Levels in Mild-Moderate Parkinson Disease Detected by 7 Tesla Proton MRS

(2012) Uzay E. Emir et al.   PLoS One

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

(2010) Per Borghammer et al.   Brain Structure & Function